🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT00271180
Recruiting Observational

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

NCT00271180 · tracked via the Priya Life Science India tracker
Sponsor
Medtronic
Phase
Observational
Started
1983-01
Last updated
2026-08-20

Condition(s) studied

ArrhythmiaBradycardiaHeart FailureSinus Tachycardia

Investigational drug(s) / intervention(s)

Device

Study summary

The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Subjects who meet the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment. Inclusion Criteria: • Subject or appropriate legal guardians provide written informed consent and/or authorization for access to and use of health information as required by an institution's IRB/MEC/REB AND one of the following must also apply: * Subject is indicated for implant or within 30 days post-implant of at least one Medtronic market-released product used for a pacing, sensing or defibrillation application * Subjects who participated in a qualifying study (IDE) of a Medtronic market-released product with complete implant and follow-up data and subject or appropriate legal guardian authorizes release of subject study data Exclusion Criteria: * Subjects who are, or will be inaccessible for follow-up * Subjects with exclusion criteria required by local law (EMEA only) * Subjects receiving an implant of a Medtronic device at a non-participating center and the implant data and current status cannot be confirmed within 30 days after implant * Subjects implanted with a Medtronic device whose predetermined enrollment limit for that specific product has been exceeded

Primary outcome measure(s)

Trial sites (333)

FacilityCityRegionStatus
Birmingham Alabama Recruiting
Anchorage Alaska Terminated
Chandler Arizona Recruiting
Jonesboro Arkansas Terminated
Little Rock Arkansas Recruiting
Bakersfield California Terminated
Chula Vista California Completed
La Jolla California Recruiting
Los Angeles California Terminated
Palm Springs California Terminated
Rancho Mirage California Terminated
Redwood City California Active Not Recruiting
Salinas California Recruiting
San Diego California Terminated
Stanford California Recruiting
Torrance California Recruiting
Van Nuys California Terminated
Ventura California Recruiting
Aurora Colorado Recruiting
Centennial Colorado Recruiting
Colorado Springs Colorado Recruiting
Denver Colorado Terminated
Lakewood Colorado Recruiting
Hartford Connecticut Recruiting
New Haven Connecticut Recruiting
Washington D.C. District of Columbia Recruiting
Bradenton Florida Terminated
Clearwater Florida Recruiting
Hollywood Florida Recruiting
Jacksonville Florida Recruiting
Panama City Florida Recruiting
Safety Harbor Florida Recruiting
Sarasota Florida Recruiting
Tampa Florida Recruiting
Atlanta Georgia Recruiting
Marietta Georgia Active Not Recruiting
Evansville Indiana Recruiting
Indianapolis Indiana Recruiting
West Des Moines Iowa Recruiting
Kansas City Kansas Recruiting

+ 293 more sites — see the full list on the official registry below.

More Medtronic trials in India

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00271180 on ClinicalTrials.gov ↗ ← All trials in India